Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer

Cancer Letters

Volumn 388, Issue , 2017, Pages 208-219

  Chen, Jie ^a,b   Li, Yan ^a,b   Zheng, Qiupeng ^a,b,c   Bao, Chunyang ^a,b   He, Jian ^a,b   Chen, Bin ^a,b   Lyu, Dongbin ^a,b   Zheng, Biqiang ^a,b   Xu, Yu ^a,b   Long, Ziwen ^a,b   Zhou, Ye ^a,b   Zhu, Huiyan ^a,b   Wang, Yanong ^a,b   He, Xianghuo ^a,b   Shi, Yingqiang ^a,b   Huang, Shenglin ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

circPVT1; Circular RNA; Gastric cancer; Non coding RNA; Prognosis

Indexed keywords

CIRCPVT1; CIRCULAR RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA; LONG UNTRANSLATED RNA; PVT1 LONG-NON-CODING RNA, HUMAN; RNA; RNA, CIRCULAR; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; STOMACH CANCER; TUMOR GROWTH; ADENOCARCINOMA; GENETICS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH TUMOR;

ADENOCARCINOMA; BIOMARKERS, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RNA; RNA, LONG NONCODING; STOMACH NEOPLASMS;

EID: 85006955772     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2016.12.006     Document Type: Article

References (29)

1. [1] Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., Jemal, A., Global cancer statistics, 2012. CA: Cancer J. Clin. 65 (2015), 87–108.
2. [2] Allemani, C., Weir, H.K., Carreira, H., Harewood, R., Spika, D., Wang, X.S., et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385 (2015), 977–1010.
3. [3] Glazar, P., Papavasileiou, P., Rajewsky, N., circBase: a database for circular RNAs. RNA 20 (2014), 1666–1670.
4. [4] Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495 (2013), 333–338.
5. [5] Salzman, J., Chen, R.E., Olsen, M.N., Wang, P.L., Brown, P.O., Cell-type specific features of circular RNA expression. PLoS Genet., 9, 2013, e1003777.
6. [6] Wang, P.L., Bao, Y., Yee, M.C., Barrett, S.P., Hogan, G.J., Olsen, M.N., et al. Circular RNA is expressed across the eukaryotic tree of life. PloS One, 9, 2014, e90859.
7. [7] Li, Y., Zheng, Q., Bao, C., Li, S., Guo, W., Zhao, J., et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 25 (2015), 981–984.
8. [8] Starke, S., Jost, I., Rossbach, O., Schneider, T., Schreiner, S., Hung, L.H., et al. Exon circularization requires canonical splice signals. Cell Rep. 10 (2015), 103–111.
9. [9] Zhang, X.O., Wang, H.B., Zhang, Y., Lu, X., Chen, L.L., Yang, L., Complementary sequence-mediated exon circularization. Cell 159 (2014), 134–147.
10. [10] Liang, D., Wilusz, J.E., Short intronic repeat sequences facilitate circular RNA production. Genes Dev. 28 (2014), 2233–2247.
11. [11] Ashwal-Fluss, R., Meyer, M., Pamudurti, N.R., Ivanov, A., Bartok, O., Hanan, M., et al. circRNA biogenesis competes with pre-mRNA splicing. Mol. Cell 56 (2014), 55–66.
12. [12] Ivanov, A., Memczak, S., Wyler, E., Torti, F., Porath, H.T., Orejuela, M.R., et al. Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep. 10 (2015), 170–177.
13. [13] Conn, S.J., Pillman, K.A., Toubia, J., Conn, V.M., Salmanidis, M., Phillips, C.A., et al. The RNA binding protein quaking regulates formation of circRNAs. Cell 160 (2015), 1125–1134.
14. [14] Chen, L.L., Yang, L., Regulation of circRNA biogenesis. RNA Biol. 12 (2015), 381–388.
15. [15] Rybak-Wolf, A., Stottmeister, C., Glazar, P., Jens, M., Pino, N., Giusti, S., et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol. Cell 58 (2015), 870–885.
16. [16] Veno, M.T., Hansen, T.B., Veno, S.T., Clausen, B.H., Grebing, M., Finsen, B., et al. Spatio-temporal regulation of circular RNA expression during porcine embryonic brain development. Genome Biol., 16, 2015, 245.
17. [17] Hansen, T.B., Jensen, T.I., Clausen, B.H., Bramsen, J.B., Finsen, B., Damgaard, C.K., et al. Natural RNA circles function as efficient microRNA sponges. Nature 495 (2013), 384–388.
18. [18] Zhao, Z.J., Shen, J., Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol., 2015, 10.1080/15476286.2015.1122162.
19. [19] Yang, W., Du, W.W., Li, X., Yee, A.J., Yang, B.B., Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis. Oncogene 35 (2016), 3919–3931.
20. [20] Li, F., Zhang, L., Li, W., Deng, J., Zheng, J., An, M., et al. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/beta-catenin pathway. Oncotarget 6 (2015), 6001–6013.
21. [21] Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., Salzberg, S.L., TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol., 14, 2013, R36.
22. [22] Jeck, W.R., Sorrentino, J.A., Wang, K., Slevin, M.K., Burd, C.E., Liu, J., et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA (New York, N.Y.) 19 (2013), 141–157.
23. [23] Coronnello, C., Benos, P.V., ComiR: combinatorial microRNA target prediction tool. Nucleic acids Res. 41 (2013), W159–W164.
24. [24] Scott, G.K., Goga, A., Bhaumik, D., Berger, C.E., Sullivan, C.S., Benz, C.C., Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem. 282 (2007), 1479–1486.
25. [25] Shaham, L., Binder, V., Gefen, N., Borkhardt, A., Izraeli, S., MiR-125 in normal and malignant hematopoiesis. Leukemia 26 (2012), 2011–2018.
26. [26] Cory, S., Graham, M., Webb, E., Corcoran, L., Adams, J.M., Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene. EMBO J. 4 (1985), 675–681.
27. [27] Colombo, T., Farina, L., Macino, G., Paci, P., PVT1: a rising star among oncogenic long noncoding RNAs. BioMed Res. Int., 2015, 2015, 304208.
28. [28] Tseng, Y.Y., Moriarity, B.S., Gong, W., Akiyama, R., Tiwari, A., Kawakami, H., et al. PVT1 dependence in cancer with MYC copy-number increase. Nature 512 (2014), 82–86.
29. [29] Wang, F., Yuan, J.H., Wang, S.B., Yang, F., Yuan, S.X., Ye, C., et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatol. (Baltim. Md.) 60 (2014), 1278–1290.